{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:47:26Z","timestamp":1772200046830,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009564","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Some patients with comorbidities and rapid disease progression have a poor prognosis.<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> We aimed to investigate the characteristics of comorbidities and their relationship with disease progression and outcomes of COVID-19 patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 718 COVID-19 patients were divided into five clinical type groups and eight age-interval groups. The characteristics of comorbidities were compared between the different clinical type groups and between the different age-interval groups, and their relationships with disease progression and outcomes of COVID-19 patients were assessed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Approximately 91.23% (655\/718) of COVID-19 patients were younger than 60 years old. Approximately 64.76% (465\/718) had one or more comorbidities, and common comorbidities included non-alcoholic fatty liver disease (NAFLD), hyperlipidaemia, hypertension, diabetes mellitus (DM), chronic hepatitis B (CHB), hyperuricaemia, and gout. COVID-19 patients with comorbidities were older, especially those with chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD). Hypertension, DM, COPD, chronic kidney disease (CKD) and CVD were mainly found in severe COVID-19 patients. According to spearman correlation analysis the number of comorbidities was correlated positively with disease severity, the number of comorbidities and NAFLD were correlated positively with virus negative conversion time, hypertension, CKD and CVD were primarily associated with those who died, and the above-mentioned correlation existed independently of age. Risk factors included age, the number of comorbidities and hyperlipidaemia for disease severity, the number of comorbidities, hyperlipidaemia, NAFLD and COPD for the virus negative conversion time, and the number of comorbidities and CKD for prognosis. Number of comorbidities and age played a predictive role in disease progression and outcomes.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Not only high number and specific comorbidities but also age are closely related to progression and poor prognosis in patients with COVID-19. These findings provide a reference for clinicians to focus on not only the number and specific comorbidities but also age in COVID-19 patients to predict disease progression and prognosis.<\/jats:p><jats:p><jats:bold>Clinical Trial Registry:<\/jats:bold> Chinese Clinical Trial Register ChiCTR2000034563.<\/jats:p>","DOI":"10.3389\/fmed.2021.736109","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T08:16:23Z","timestamp":1641543383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19"],"prefix":"10.3389","volume":"8","author":[{"given":"Dafeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifang","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J Med Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jmv.25682","article-title":"Cross-species transmission of the newly identified coronavirus 2019-nCoV","volume":"92","author":"Ji","year":"2020","journal-title":"J Med Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMp2003762","article-title":"Responding to COVID-19- a once-in-a-century pandemic?","volume":"382","author":"Gates","year":"2020","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature."},{"key":"B6","unstructured":"Weekly Epidemiological Update on COVID-19.2021"},{"key":"B7","unstructured":"The Seventh Trial Version of the Novel Coronavirus Pneumonia Diagnosis and Treatment Guidance.2019"},{"key":"B8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of 2019 novel coronavirus infection in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3201\/eid2606.200320","article-title":"Case-fatality risk estimates for COVID-19 calculated by using a lag time for fatality","volume":"26","author":"Wilson","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1371\/journal.pone.0241265","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch Acad Emerg Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.18502\/ijaai.v20i2.6047","article-title":"Clinical presentation of iranian patients affected with COVID-19: a thousand faces disease","volume":"20","author":"Mostafaei","year":"2021","journal-title":"Iran J Allergy Asthma Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"593256","DOI":"10.3389\/fpubh.2020.593256","article-title":"Assessing the severity of illness in patients with coronavirus disease in Saudi Arabia: a retrospective descriptive cross-sectional study","volume":"8","author":"Alqahtani","year":"2020","journal-title":"Front Public Health."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"55","author":"Guan","year":"2020","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"100519","DOI":"10.1016\/j.eclinm.2020.100519","article-title":"Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: a systematic review and meta-analysis","volume":"26","author":"Park","year":"2020","journal-title":"E Clin Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its impact on patients with COVID-19","volume":"2","author":"Sanyaolu","year":"2020","journal-title":"SN Compr Clin Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00277-020-04328-4","article-title":"COVID-19 in cancer patients: clinical characteristics and outcome\u2014an analysis of the LEOSS registry","volume":"100","author":"R\u00fcthrich","year":"2021","journal-title":"Ann Hematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijbs.50654","article-title":"Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study","volume":"17","author":"Lv","year":"2021","journal-title":"Int J Biol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.lanwpc.2021.100108","article-title":"Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study","volume":"9","author":"Surendra","year":"2021","journal-title":"Lancet Reg Health West Pac."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/hep4.1592","article-title":"Clinical features of COVID-19 patients with non-alcoholic fatty liver disease","volume":"4","author":"Huang","year":"2020","journal-title":"Hepatol Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1007\/s00261-020-02648-7","article-title":"Higher frequency of hepatic steatosis at CT among COVID-19-positive patients","volume":"45","author":"Medeiros","year":"2020","journal-title":"Abdom Radiol (NY)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.metop.2020.100057","article-title":"The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study","volume":"8","author":"Ghoneim","year":"2020","journal-title":"Metabol Open."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e927212","DOI":"10.12659\/MSM.927212","article-title":"Clinical Characteristics and outcomes of patients with severe COVID-19 and chronic obstructive pulmonary disease (COPD)","volume":"26","author":"He","year":"2020","journal-title":"Med Sci Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.numecd.2020.07.031","article-title":"Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study","volume":"30","author":"Di Castelnuovo","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut."},{"key":"B29","doi-asserted-by":"publisher","first-page":"626425","DOI":"10.3389\/fmed.2021.626425","article-title":"Metabolic associated fatty liver disease is associated with an increased risk of severe COVID-19: a systematic review with meta-analysis","volume":"8","author":"Hegyi","year":"2021","journal-title":"Front Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.dsx.2021.03.019","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00631-3","article-title":"NAFLD and COVID-19: a pooled analysis","volume":"2020","author":"Sachdeva","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.dld.2021.01.019","article-title":"Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19","volume":"53","author":"Campos-Murgu\u00eda","year":"2021","journal-title":"Dig Liver Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"604100","DOI":"10.3389\/fendo.2021.604100","article-title":"Association and interaction between serum interleukin-6 levels and metabolic dysfunction-associated fatty liver disease in patients with severe coronavirus disease 2019","volume":"12","author":"Gao","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jhep.2020.09.006","article-title":"NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues","volume":"74","author":"Mushtaq","year":"2021","journal-title":"J Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"104219","DOI":"10.1016\/j.compbiomed.2021.104219","article-title":"A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?","volume":"130","author":"Singh","year":"2021","journal-title":"Comput Biol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jhep.2020.04.035","article-title":"No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease","volume":"73","author":"Biquard","year":"2020","journal-title":"J Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jhep.2020.12.007","article-title":"Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD","volume":"74","author":"Meijnikman","year":"2021","journal-title":"J Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3389\/fimmu.2019.02694","article-title":"Understanding the heterogeneity of resident liver macrophages","volume":"10","author":"Bl\u00e9riot","year":"2019","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases- diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.3748\/wjg.v26.i48.7693","article-title":"High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data","volume":"26","author":"D\u00edaz","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153451","DOI":"10.1016\/j.prp.2021.153451","article-title":"Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens","volume":"221","author":"Fassan","year":"2021","journal-title":"Pathol Res Pract."},{"key":"B43","doi-asserted-by":"publisher","first-page":"969","DOI":"10.4254\/wjh.v13.i9.969","article-title":"Coronavirus disease 2019 and non-alcoholic fatty liver disease","volume":"13","author":"Bellanti","year":"2021","journal-title":"World J Hepatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.736109\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T08:16:30Z","timestamp":1641543390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.736109\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":43,"alternative-id":["10.3389\/fmed.2021.736109"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.736109","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"article-number":"736109"}}